[REGN] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
02-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 15.36%
YoY- 42.21%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 5,138,500 1,952,000 1,933,700 1,608,022 1,470,116 1,212,629 998,617 31.36%
PBT 3,752,800 918,900 224,700 656,074 525,850 292,256 327,996 50.05%
Tax 653,900 21,600 31,600 104,662 138,106 96,038 133,353 30.31%
NP 3,098,900 897,300 193,100 551,412 387,744 196,218 194,643 58.54%
Tax Rate -17.42% -2.35% -14.06% -15.95% -26.26% -32.86% -40.66% -
Total Cost 2,039,600 1,054,700 1,740,600 1,056,610 1,082,372 1,016,411 803,974 16.76%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 60.31 45.97 9.99 34.29 26.38 16.18 19.49 20.69%
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS 29.51 8.19 1.77 5.12 3.66 1.88 1.89 58.02%
EPS Diluted 27.97 7.61 1.68 4.82 3.34 1.69 1.69 59.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.